References
1. New York City Department of Health and Mental Hygiene. Influenza Surveillance. 2024. Available from: https://www.nyc.gov/site/doh/data/health-tools/flu.page
2. Centers for Disease Control and Prevention. People at Higher Risk of Flu Complications. Updated September 2024. Available from: https://www.cdc.gov/flu/highrisk/index.htm
3. Centers for Disease Control and Prevention. Flu Symptoms & Complications. Updated August 2024. Available from: https://www.cdc.gov/flu/symptoms/symptoms.htm
4. Urgent Care Association. Urgent Care Data. https://urgentcareassociation.org/about/urgent-care-data/
5. Poyorena, C., Patel, S., Keim, A., Monas, J., Urumov, A., Lindor, R., Girardo, M., & Rappaport, D. (2022). Evaluating urgent care center referrals to the emergency department. Journal of the American College of Emergency Physicians open, 3(6), e12838. https://doi.org/10.1002/emp2.12838
6. Tenforde, M. W., Noah, K. P., O’Halloran, A. C., Daily Kirley, P., Hoover, C., Alden, N. B., Armistead, I., Meek, J., Yousey‑Hindes, K., Openo, K. P., Witt, L. S., Monroe, M. L., Ryan, P. A., Falkowski, A., Reeg, L., Lynfield, R., McMahon, M., Hancock, E. B., Hoffman, M. R., McGuire, S., Spina, N. L., Felsen, C. B., Gaitan, M. A., Lung, K., Shiltz, E., Thomas, A., Schaffner, W., Talbot, H. K., Crossland, M. T., Price, A., Masalovich, S., Adams, K., Holstein, R., Sundaresan, D., Uyeki, T. M., Reed, C., Bozio, C. H., & Garg, S. (2025). Timing of Influenza Antiviral Therapy and Risk of Death in Adults Hospitalized With Influenza‑Associated Pneumonia, Influenza Hospitalization Surveillance Network (FluSurv‑NET), 2012–2019. Clinical Infectious Diseases, 80(2), 461–468. https://academic.oup.com/cid/article/80/2/461/7739088
7. Centers for Disease Control and Prevention. Influenza Antiviral Medications: Summary for Clinicians. Updated November 2023. Available from: https://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm
8. Hayden FG, Sugaya N, Hirotsu N, et al. Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents. New England Journal of Medicine. 2018;379(10):913-923. https://www.nejm.org/doi/full/10.1056/NEJMoa1716197
9. Jefferson T, Jones MA, Doshi P, et al. Neuraminidase Inhibitors for Preventing and Treating Influenza in Healthy Adults and Children. Cochrane Database of Systematic Reviews. 2014;(4):CD008965. https://pubmed.ncbi.nlm.nih.gov/24718923/
10. Uyeki TM, Bernstein HH, Bradley JS, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza. Clinical Infectious Diseases. 2019;68(6):e1-e47. https://pubmed.ncbi.nlm.nih.gov/30566567/
11. Centers for Disease Control and Prevention. How Flu Spreads. Updated September 2024. Available from: https://www.cdc.gov/flu/about/disease/spread.htm
12. Allan GM, Arroll B. Prevention and Treatment of the Common Cold: Making Sense of the Evidence. Canadian Medical Association Journal. 2014;186(3):190-199. https://pmc.ncbi.nlm.nih.gov/articles/PMC3928210/
13. Rothberg MB, Haessler SD, Brown RB. Complications of Viral Influenza. American Journal of Medicine. 2008;121(4):258-264. https://pubmed.ncbi.nlm.nih.gov/18374680/
14. Morens DM, Taubenberger JK, Fauci AS. Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza Preparedness. Journal of Infectious Diseases. 2008;198(7):962-970. https://pmc.ncbi.nlm.nih.gov/articles/PMC2599911/
15. Sellers SA, Hagan RS, Hayden FG, Fischer WA. The Hidden Burden of Influenza: A Review of the Extra-Pulmonary Complications of Influenza Infection. Influenza and Other Respiratory Viruses. 2017;11(5):372-393. https://pmc.ncbi.nlm.nih.gov/articles/PMC5596521/
16. Centers for Disease Control and Prevention. Vaccine Effectiveness: How Well Do Flu Vaccines Work? Updated October 2024. Available from: https://www.cdc.gov/flu/vaccines-work/vaccineeffect.htm